gadolinium has been researched along with Thyroid Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, J; Hu, Z; Li, T; Qin, J | 1 |
| Gao, S; Guo, L; Nie, S; Qi, M; Wang, K | 1 |
| Bertoldi, EG; de Azevedo, MJ; Foppa, M; Maia, AL; Scheffel, RS; Severo, MD | 1 |
| Adjei, ON; Flores, LG; Futami, S; Jinnouchi, S; Kodama, T; Murakami, N; Nagamachi, S; Nakahara, H; Noguchi, S; Ohnishi, T; Tamura, S; Watanabe, K | 1 |
1 review(s) available for gadolinium and Thyroid Neoplasms
| Article | Year |
|---|---|
Left atrial metastases of poorly differentiated thyroid carcinoma diagnosed by echocardiography and magnetic resonance imaging--case report and review of literature.
Topics: Contrast Media; Diagnosis, Differential; Fatal Outcome; Female; Follow-Up Studies; Gadolinium; Heart Atria; Heart Neoplasms; Humans; Image Enhancement; Magnetic Resonance Imaging; Middle Aged; Neoplasms, Second Primary; Pneumonia; Thyroid Neoplasms; Ultrasonography | 2012 |
3 other study(ies) available for gadolinium and Thyroid Neoplasms
| Article | Year |
|---|---|
Thyroid cancer MR molecular imaging via SHP2-targeted nanoparticles.
Topics: Animals; Apoptosis; Cell Line, Tumor; Contrast Media; Fluorocarbons; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Molecular Imaging; Nanoparticles; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Thyroid Neoplasms | 2019 |
Precise engineering of cetuximab encapsulated gadollium nanoassemblies:
Topics: Animals; Antineoplastic Agents, Immunological; Apoptosis; Cell Line, Tumor; Cetuximab; Chemistry, Pharmaceutical; Drug Carriers; Drug Stability; Female; Fluorocarbons; Gadolinium; Humans; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Nanoparticles; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Ultrasonography, Interventional | 2021 |
Gadolinium-enhanced MR imaging of thyroid and parathyroid masses.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Parathyroid Neoplasms; Pentetic Acid; Thyroid Neoplasms | 1997 |